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Introduction {#acn3633-sec-0005}
============

Cigarette smoking is one of the most important causes of preventable death in the world.[1](#acn3633-bib-0001){ref-type="ref"} At least 14 million cases of serious morbidities are known to attributed by the smoking in the United States,[2](#acn3633-bib-0002){ref-type="ref"} including chronic obstructive pulmonary disease, cardiovascular disease,[3](#acn3633-bib-0003){ref-type="ref"} stroke,[4](#acn3633-bib-0004){ref-type="ref"} and cancer.[5](#acn3633-bib-0005){ref-type="ref"} It is also known that 480,000 deaths are attributable to smoking in the United States alone.[6](#acn3633-bib-0006){ref-type="ref"} However, relatively less is known on the risk of smoking on neurodegenerative disease. Interestingly, early studies funded by the tobacco company have suggested a possible beneficial role of smoking in cognitive function due to the effects of nicotine.[7](#acn3633-bib-0007){ref-type="ref"} Furthermore, several early case--control studies funded by the tobacco industry have reported a preventive effect of smoking on Alzheimer\'s disease.[8](#acn3633-bib-0008){ref-type="ref"}, [9](#acn3633-bib-0009){ref-type="ref"}, [10](#acn3633-bib-0010){ref-type="ref"} However, since then, a number of cohort studies have shown that smoking was associated with increased risk of dementia.[11](#acn3633-bib-0011){ref-type="ref"} The most recent longitudinal study with a long‐term follow‐up duration[12](#acn3633-bib-0012){ref-type="ref"} and meta‐analysis[13](#acn3633-bib-0013){ref-type="ref"} have also reported smoking as a risk factor for dementia.

As there appears to be a consensus on the risk increasing effect of smoking on dementia,[14](#acn3633-bib-0014){ref-type="ref"}, [15](#acn3633-bib-0015){ref-type="ref"} it is important to address whether or not smoking habit change, namely smoking cessation, alters the risk of developing dementia next. However, only a few previous studies investigating the association of smoking on dementia evaluated the effect of smoking cessation.[12](#acn3633-bib-0012){ref-type="ref"}, [13](#acn3633-bib-0013){ref-type="ref"}, [16](#acn3633-bib-0016){ref-type="ref"} Numerous studies have compared current, former and never smokers, but few if any studies have examined duration of smoking cessation. Finally, most studies investigating the effect of smoking on dementia were conducted with Western populations,[13](#acn3633-bib-0013){ref-type="ref"}, [17](#acn3633-bib-0017){ref-type="ref"} with relatively few studies conducted in Asia. As there are differences in prevalence[18](#acn3633-bib-0018){ref-type="ref"} and type distribution[19](#acn3633-bib-0019){ref-type="ref"} of dementia among Western and Asian populations, the effect of smoking on the risk of dementia might also differ between ethnic groups. Therefore, we aimed to investigate the effect of smoking habit change on the risk of developing dementia in this population‐based study using the Korean National Health Insurance System -- National Health Screening Cohort (NHIS‐HealS).

Methods {#acn3633-sec-0006}
=======

Study population {#acn3633-sec-0007}
----------------

The National Health Insurance Service (NHIS) of Korea provides mandatory health insurance for Korean citizens since the National Health Insurance Act in 1989.[20](#acn3633-bib-0020){ref-type="ref"}, [21](#acn3633-bib-0021){ref-type="ref"} With an enrollment rate of 97%, the NHIS provides biannual health examinations for all enrollees who turn 40 years old. Using data from the health examinations, the NHIS constructs and provides datasets by a simple random sampling method. The constructed cohort, NHIS‐HealS, provides information on sociodemographics, hospital use, examinations, pharmacy visits and other data, which can be used for research purposes. The data used in this study is directly available via the NHIS database registration system. A number of previous studies have used this NHIS database for epidemiological studies, and its validity has been described in detail elsewhere.[22](#acn3633-bib-0022){ref-type="ref"}, [23](#acn3633-bib-0023){ref-type="ref"}

A total of 51,849 men aged 60 years or older who participated in health examinations between the first (2002 to 2003) and second (2004 to 2005) periods were recruited. Among them, those without information on smoking habit (4744 participants) were excluded. Furthermore, 362 participants who died and 603 participants who were diagnosed with dementia before the index date of January 1, 2006 were excluded. Women were excluded due to extremely low smoking rates in Korea. Ultimately, the final study population consisted of 46,140 participants.

Smoking habit change {#acn3633-sec-0008}
--------------------

The smoking status of the study participants were assessed by a questionnaire during the health examination. Based on the answers to the questionnaire from both the first and second health examinations, the participants were divided into continual smokers, short‐term quitters (quitting duration of less than 4 years), long‐term quitters (quitting duration of 4 years or longer), and never smokers.[24](#acn3633-bib-0024){ref-type="ref"} Continual smokers were participants who were current smokers during the first and second health examinations. Short‐term quitters were defined was those who were current smokers during the first health examination but quitters during the second health examination. Long‐term quitters were those who were quitters for both the first and second health examinations. Finally, never smokers were defined as those who were never smokers for both the first and second health examinations.

Assessment of dementia {#acn3633-sec-0009}
----------------------

Hospital use records, including hospitalizations and outpatient visits were used to identify new cases of dementia. Dementia was defined using the codes from the Tenth Revision of International Classification of Diseases (ICD‐10) from the World Health Organization. Participants who were hospitalized at least once or visited the outpatient department at least three times with an ICD‐10 code pertaining to dementia (F00, F01, F02, F03, G30, G31, and G32) were considered to have developed dementia.[25](#acn3633-bib-0025){ref-type="ref"} Since it is required to fulfill Korean National Health Insurance reimbursement criteria to receive payment in Korea, physicians need to document the evidence for cognitive dysfunction according to strict criteria to submit a valid claim for: (1) Minimal Mental State Examination score ≤ 26 and (2) either a Clinical Dementia Rating ≥ 1 or a Global Deterioration Scale score ≥ 3.[26](#acn3633-bib-0026){ref-type="ref"}, [27](#acn3633-bib-0027){ref-type="ref"} Among dementia patients, we further categorized patients with Alzheimer\'s disease (F00 or G30) and vascular dementia (F01). The earliest date of hospital use with an ICD‐10 code pertaining to dementia was considered the date of diagnosis for dementia patients.

Covariates {#acn3633-sec-0010}
----------

Information on potential confounding covariates was extracted from 2005 and missing values were categorized into a separate group for each covariates. The covariates considered were age, body mass index (\<18.5, 18.5--22.9, 23.0--24.9, and ≥25.0 kg/m^2^), blood pressure (\<120/80, 120/80‐139/89, and ≥140/90 mmHg), fasting serum glucose (\<100.0, 100.0--125.9, ≥126.0 mg/dL, and missing), total cholesterol (\<200.0, 200.0--239.9, ≥240.0 mg/dL, and missing), physical activity (none, 1--2, 3--4, 5--7 times per week, and missing), drinking habit (none, 1--2, ≥3 drinks per week, and missing), and household income (lower half and upper half). Household income was categorized according to each patient\'s insurance premium status. Finally, Charlson Comorbidity Index (CCI, 0, 1--2, and ≥3), another potential confounding covariate, was extracted from 2002 to 2005. The algorithm for CCI calculation by ICD‐10 codes was adapted from a previous study.[28](#acn3633-bib-0028){ref-type="ref"}

Statistical analysis {#acn3633-sec-0011}
--------------------

All participants were followed‐up starting January 1, 2006 and ended at the date of dementia diagnosis, date of death, or December 31, 2013, whichever came first. Taking into account the fact that dementia is a chronic, slowly developing disorder while also trying to minimize the possibility of reverse‐causality, we applied a washout‐period of 5 years, in which we did not consider new cases of dementia for those diagnosed from January 1, 2006 to December 31, 2010. The risk of developing dementia due to smoking habit change was assessed by calculating the hazard ratios (HRs) and 95% confidence intervals (95% CI) using Cox proportional hazards regression analyses. In all analyses, the continual smoker group was used as the reference group, in which the HR and 95% CI was calculated for the short‐term quitter, long‐term quitter, and never smoker groups.

Multivariable‐adjusted (adjusted for age, household income, physical activity, drinking habit, body mass index, change in body mass index, blood pressure, fasting serum glucose, total cholesterol, and Charlson Comorbidity Index) analyses were conducted for the risk of overall dementia, Alzheimer\'s disease, and vascular dementia. Furthermore, *P* for trend values were calculated in the order of continual smoker, short‐term quitter, long‐term quitter, and never smoker, which pertains to decreasing amounts of total tobacco exposure. Stratified, multivariate‐adjusted analyses according to subgroups divided by covariates were conducted. Sensitivity analysis was conducted by changing the washout period of dementia cases by 6 years and 7 years. Finally, the association between smoking habit change and dementia among women was determined.

Statistical significance was defined as a *p* value of less than 0.05 in a two‐sided manner. Statistical software SAS 9.3 (SAS Institute, Cary, NC) and STATA 13.0 (StataCorp LP, College Station, TX) were used for data collection and statistical analyses, respectively.

IRB approval {#acn3633-sec-0012}
------------

This study was approved by the Seoul National University Hospital Institutional Review Board (IRB number: X‐1701/378‐902). The IRB waived the requirement for informed consent from the study participants as the NHIS‐HealS database is anonymized according to strict confidentiality guidelines.

Results {#acn3633-sec-0013}
=======

A total of 46,140 participants were followed up for a mean of 7.11 years, with 328,274 person‐years. Table [1](#acn3633-tbl-0001){ref-type="table"} depicts the descriptive characteristics of the study population. The number continual smokers, short‐term quitters, long‐term quitters, and never smokers were 12,672, 4,175, 9,268, and 20,025 men, respectively. The majority of participants were aged between 60 and 69 years, with the group containing the highest proportion of men aged between 60 and 69 years being continual smokers. Furthermore, compared to other groups, continual smokers tended to have lower body mass index, lower blood pressure, exercise less, drink alcohol more, and have lower household income.

###### 

Descriptive characteristics of study participants

                                         Change in Smoking Status                 
  -------------------------------------- -------------------------- ------ ------ --------
  Number of people                       12,672                     4175   9268   20,025
  Age, years, %                                                                   
  60--69                                 77.1                       74.4   68.2   70.8
  70 or older                            22.9                       25.6   31.9   29.2
  Body mass index, kg/m^2^, %                                                     
  \<18.5                                 5.9                        4.6    3.3    2.8
  18.5--22.9                             46.0                       42.1   35.8   35.6
  23.0--24.9                             25.3                       27.0   29.2   28.5
  ≥25.0                                  22.9                       26.3   31.7   33.1
  Blood pressure, mmHg, %                                                         
  \<120/80                               18.9                       17.9   16.5   16.1
  120/80--139/89                         60.4                       60.8   62.7   61.3
  ≥140/90                                20.7                       21.2   20.9   22.6
  Missing                                0.0                        0.0    0.0    0.0
  Fasting serum glucose, mg/dL, %                                                 
  \<100.0                                60.9                       59.7   59.1   60.0
  100.0--125.9                           27.7                       28.5   30.0   29.1
  ≥126.0                                 11.3                       11.7   10.8   10.8
  Missing                                0.1                        0.1    0.1    0.1
  Total cholesterol, mg/dL, %                                                     
  \<200.0                                61.1                       60.1   60.0   61.5
  200.0--239.9                           29.0                       29.9   29.5   29.2
  ≥240.0                                 9.8                        9.8    10.3   9.1
  Missing                                0.1                        0.1    0.1    0.1
  Physical activity, times per week, %                                            
  None                                   59.8                       58.4   47.2   47.2
  1--2                                   18.8                       17.8   20.7   21.5
  3--4                                   7.9                        8.4    11.4   11.3
  5--7                                   12.8                       12.4   19.1   18.7
  Missing                                0.7                        3.0    1.6    1.3
  Drinking habit, drinks per week, %                                              
  None                                   34.6                       56.4   43.6   58.0
  1--2                                   34.6                       25.0   33.5   27.4
  ≥3                                     30.6                       16.9   22.2   14.4
  Missing                                0.2                        1.8    0.7    0.2
  Household income, %                                                             
  Lower half                             51.5                       48.1   39.2   39.7
  Upper half                             47.8                       50.9   60.3   59.7
  Missing                                0.8                        1.0    0.6    0.5
  Charlson comorbidity index, %                                                   
  0                                      24.5                       20.1   19.8   21.8
  1--2                                   48.7                       47.0   47.0   46.5
  ≥3                                     26.8                       33.0   33.3   31.7
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Table [2](#acn3633-tbl-0002){ref-type="table"} shows the effect of smoking habit change on the risk of dementia. A total of 1644 participants were diagnosed with dementia during the follow‐up duration. Compared to continual smokers, long‐term quitters and never smokers had decreased risk of overall dementia (HR: 0.86; 95% CI: 0.75--0.99 and HR: 0.81; 95% CI: 0.71--0.91, respectively). Furthermore, as the total amount of tobacco exposed decreased in order of continual smokers, short‐term quitters, long‐term quitters, and never smokers, the risk of developing overall dementia significantly decreased (*P* for trend 0.001). Similarly, never smokers had decreased risk of developing Alzheimer\'s disease (HR 0.82 95% CI 0.70--0.96) compared to continual smokers. Finally, long‐term quitters and never smokers also had decreased risk of vascular dementia (HR: 0.68; 95% CI: 0.48--0.96, HR: 0.71; 95% CI: 0.54--0.95, respectively) compared to continual smokers.

###### 

Effect of smoking habit change on the risk of developing dementia

  Dementia type                                       Change in smoking status   *p* for trend                                               
  --------------------------------------------------- -------------------------- ------------------- ------------------- ------------------- -------
  Overall dementia                                                                                                                           
  Number of cases                                     468                        146                 342                 688                 
  Person‐years                                        87,040                     28,546              63,793              141,263             
  HR[a](#acn3633-note-0006){ref-type="fn"} (95% CI)   1.00 (reference)           0.87 (0.72--1.05)   0.86 (0.75--0.99)   0.81 (0.71--0.91)   0.001
  Alzheimer\'s disease                                                                                                                       
  Number of cases                                     294                        99                  219                 451                 
  Person‐years                                        90,064                     29,550              66,483              146,723             
  HR[a](#acn3633-note-0006){ref-type="fn"} (95% CI)   1.00 (reference)           0.92 (0.73--1.16)   0.85 (0.71--1.02)   0.82 (0.70--0.96)   0.010
  Vascular dementia                                                                                                                          
  Number of cases                                     95                         27                  53                  121                 
  Person‐years                                        91,327                     30,136              67,788              149,094             
  HR[a](#acn3633-note-0006){ref-type="fn"} (95% CI)   1.00 (reference)           0.81 (0.52--1.25)   0.68 (0.48--0.96)   0.71 (0.54--0.95)   0.017

HR, hazard ratio; CI, confidence interval.

Hazard ratio calculated by Cox proportional hazards regression analysis adjusted for age, household income, physical activity, drinking habit, body mass index, change in body mass index, blood pressure, fasting serum glucose, total cholesterol, and Charlson Comorbidity Index.

John Wiley & Sons, Ltd

Table [3](#acn3633-tbl-0003){ref-type="table"} shows stratified, multivariate‐adjusted analyses according to subgroups divided by covariates for the risk of overall dementia. Never smokers tended to have decreased risk of overall dementia compared to continual smokers, albeit with attenuated results, most likely due to the decreased number of cases upon dividing the study population by subgroups. Similarly, compared to continual smokers, long‐term quitters tended to have decreased risk of overall dementia, although most values were not statistically significant.

###### 

Stratified, multivariate‐adjusted analysis according the subgroups divided by covariates for the risk of any dementia

                                      Change in Smoking Status                                                                    
  ----------------------------------- --------------------------------------------------- ------------------- ------------------- -------------------
  Age, years                          HR[a](#acn3633-note-0006){ref-type="fn"} (95% CI)                                           
  60--69                              1.00 (reference)                                    0.84 (0.66--1.08)   0.80 (0.66--0.98)   0.78 (0.66--0.92)
  70 or older                         1.00 (reference)                                    0.94 (0.70--1.26)   1.04 (0.84--1.28)   0.93 (0.77--1.13)
  BMI, kg/m^2^                                                                                                                    
  \<25.0                              1.00 (reference)                                    0.88 (0.74--1.04)   0.92 (0.81--1.04)   0.80 (0.72--0.89)
  ≥25.0                               1.00 (reference)                                    1.11 (0.75--1.64)   0.91 (0.67--1.24)   1.06 (0.82--1.38)
  BMI change, kg/m^2^                                                                                                             
  ≤‐1.0                               1.00 (reference)                                    0.58 (0.35--0.97)   0.71 (0.52--0.97)   0.91 (0.71--1.16)
  ‐0.9 \~ +0.9                        1.00 (reference)                                    1.01 (0.80--1.29)   0.93 (0.78--1.12)   0.81 (0.69--0.95)
  ≥ +1.0                              1.00 (reference)                                    0.76 (0.51--1.14)   0.84 (0.60--1.18)   0.68 (0.50--0.92)
  Blood pressure, mmHg                                                                                                            
  \<140/90                            1.00 (reference)                                    0.81 (0.65--1.01)   0.89 (0.76--1.04)   0.77 (0.67--0.88)
  ≥140/90                             1.00 (reference)                                    1.10 (0.74--1.61)   0.76 (0.55--1.06)   0.95 (0.73--1.24)
  Fasting serum glucose, mg/dL                                                                                                    
  \<100.0                             1.00 (reference)                                    0.99 (0.77--1.26)   0.93 (0.77--1.12)   0.91 (0.77--1.07)
  ≥100.0                              1.00 (reference)                                    0.72 (0.53--0.97)   0.77 (0.62--0.96)   0.68 (0.56--0.82)
  Total cholesterol, mg/dL                                                                                                        
  \<200.0                             1.00 (reference)                                    0.93 (0.74--1.18)   0.84 (0.70--0.99)   0.77 (0.66--0.90)
  ≥200.0                              1.00 (reference)                                    0.78 (0.56--1.08)   0.90 (0.71--1.14)   0.87 (0.71--1.06)
  Physical activity, times per week                                                                                               
  None                                1.00 (reference)                                    0.88 (0.70--1.12)   0.86 (0.72--1.03)   0.79 (0.68--0.93)
  1 or more                           1.00 (reference)                                    0.87 (0.63--1.20)   0.88 (0.70--1.11)   0.83 (0.68--1.01)
  Drinking habit, drinks per week                                                                                                 
  None                                1.00 (reference)                                    0.97 (0.74--1.26)   0.92 (0.74--1.15)   0.88 (0.73--1.06)
  1 or more                           1.00 (reference)                                    0.80 (0.60--1.06)   0.82 (0.68--0.99)   0.74 (0.62--0.87)
  Household income, %                                                                                                             
  Lower half                          1.00 (reference)                                    0.86 (0.66--1.12)   0.82 (0.66--1.01)   0.74 (0.62--0.89)
  Upper half                          1.00 (reference)                                    0.93 (0.71--1.21)   0.91 (0.75--1.11)   0.88 (0.74--1.04)
  Charlson comorbidity index, %                                                                                                   
  0                                   1.00 (reference)                                    1.11 (0.69--1.81)   1.04 (0.72--1.49)   0.88 (0.64--1.20)
  1 or more                           1.00 (reference)                                    0.85 (0.69--1.04)   0.84 (0.72--0.99)   0.80 (0.70--0.92)

BMI, body mass index; HR, hazard ratio; CI, confidence interval.

Hazard ratio calculated by Cox proportional hazards regression analysis adjusted for age, household income, physical activity, drinking habit, body mass index, change in body mass index, blood pressure, fasting serum glucose, total cholesterol, and Charlson Comorbidity Index.
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The results of the sensitivity analyses by changing the duration of washout period to 6 years and 7 years are shown in Table [S1](#acn3633-sup-0001){ref-type="supplementary-material"}. There was a tendency toward decreased risk of overall dementia, Alzheimer\'s disease, and vascular dementia for long‐term quitters and never smokers, albeit with statistical attenuation due to the decreased number of events. Similarly, there was a tendency toward reduced risk of dementia according to decreasing amounts of tobacco exposed after washout periods of 6 and 7 years. In addition, the effect of smoking habit change on the risk of dementia with never smoker being the reference group is shown in Table [S2](#acn3633-sup-0001){ref-type="supplementary-material"}. Compared to never smokers, long‐term quitters and short‐term quitters was not associated with increased risk of dementia (HR: 1.07; 95% CI: 0.94--1.22, HR: 1.08; 95% CI: 0.90--1.29, respectively), but continual smokers had increased risk of dementia (HR: 1.24; 95% CI: 1.10--1.40). Finally, the association between smoking habit change and dementia among women is shown in Table [S3](#acn3633-sup-0001){ref-type="supplementary-material"}. There was a tendency toward a reduced risk of dementia according to a decreasing amount of tobacco exposure without significant result.

Discussion {#acn3633-sec-0014}
==========

In this large‐scale longitudinal study, we have shown that prolonged smoking cessation was associated with decreased risk of overall dementia among Korean men. While numerous previous studies[12](#acn3633-bib-0012){ref-type="ref"}, [13](#acn3633-bib-0013){ref-type="ref"}, [16](#acn3633-bib-0016){ref-type="ref"} have shown that smoking increases the risk of dementia in Western populations, to the best of our knowledge, this is the first study to evaluate the effects of smoking cessation on the risk of developing dementia in a large Asian population.

Results from most previous studies investigating the association between smoking and dementia are consistent with the findings in this study.[10](#acn3633-bib-0010){ref-type="ref"}, [12](#acn3633-bib-0012){ref-type="ref"}, [13](#acn3633-bib-0013){ref-type="ref"}, [29](#acn3633-bib-0029){ref-type="ref"} A recent meta‐analysis of 19 prospective studies and 26,374 participants revealed that current smokers had increased risk of Alzheimer\'s disease (relative risk, RR: 1.79; 95% CI: 1.43--2.23), vascular dementia (RR: 1.79; 95% CI: 1.28--2.47), and overall dementia (RR: 1.27; 95% CI: 1.02--1.60) compared with never smokers.[13](#acn3633-bib-0013){ref-type="ref"} Furthermore, another previous study studying the effects of smoking on dementia in the Western population revealed that former smokers had decreased risk of dementia compared to current smokers (RR: 1.70; 95% CI: 1.25--2.31).[13](#acn3633-bib-0013){ref-type="ref"} The results from this study support previous studies by showing never smokers had decreased risk of dementia compared to continual smokers. Furthermore, this study demonstrates that smokers who quit for a prolonged period benefit from decreased risk of overall dementia among Korean men.

Previous studies investigating the association between smoking and Alzheimer\'s disease have been controversial. Few studies have shown that nicotine may actually improve short‐term cognitive performance[7](#acn3633-bib-0007){ref-type="ref"}, [30](#acn3633-bib-0030){ref-type="ref"} and inhibit amyloid formation.[31](#acn3633-bib-0031){ref-type="ref"}, [32](#acn3633-bib-0032){ref-type="ref"} On the other hand, various other studies have shown that smoking is a risk factor for Alzheimer\'s disease, namely due to reactive oxygen species produced by smoking.[33](#acn3633-bib-0033){ref-type="ref"}, [34](#acn3633-bib-0034){ref-type="ref"}, [35](#acn3633-bib-0035){ref-type="ref"}, [36](#acn3633-bib-0036){ref-type="ref"}, [37](#acn3633-bib-0037){ref-type="ref"} Smoking directly delivers reactive oxidant species from the cigarette into the bloodstream, promotes the generation of endogenous reactive oxidant species and causes weakening of antioxidant defense systems.[38](#acn3633-bib-0038){ref-type="ref"}, [39](#acn3633-bib-0039){ref-type="ref"} Reactive oxygen species caused by smoking can then contribute to cellular damage by oxidizing lipids, proteins, and nucleic acids.[38](#acn3633-bib-0038){ref-type="ref"} Specifically, the brain is particularly susceptible to oxidative stress due to the high proportion of oxidizable polyunsaturated fatty acids in membranes and the high metabolic requirement of oxygen.[40](#acn3633-bib-0040){ref-type="ref"}

In our study, there was a tendency toward decreased risk of Alzheimer\'s disease upon decreasing amounts of tobacco consumed. The trend toward risk reduction upon decreasing amounts of tobacco implies that the detrimental effects of tobacco on the development of dementia. Therefore, smoking should be considered a risk factor for Alzheimer\'s disease and smoking cessation should be encouraged in order to reduce the risk of developing Alzheimer\'s disease.

Smoking is also known to increase the risk of cardiovascular diseases through oxidative damage,[3](#acn3633-bib-0003){ref-type="ref"}, [39](#acn3633-bib-0039){ref-type="ref"} increased fibrinogen levels[3](#acn3633-bib-0003){ref-type="ref"}, [41](#acn3633-bib-0041){ref-type="ref"} and induction of a hypercoagulable state.[42](#acn3633-bib-0042){ref-type="ref"} Since cerebrovascular infarction is the key pathophysiological mechanism for vascular dementia, the risk factors of cerebrovascular diseases, which include smoking,[43](#acn3633-bib-0043){ref-type="ref"}, [44](#acn3633-bib-0044){ref-type="ref"} are also considered to be risk factors of vascular dementia. As smoking cessation reduces the risk of cardiovascular disease due to decreased inflammatory markers and oxidative stress[45](#acn3633-bib-0045){ref-type="ref"}, [46](#acn3633-bib-0046){ref-type="ref"}, [47](#acn3633-bib-0047){ref-type="ref"} upon smoking cessation, similar mechanisms may contribute to the decreased risk of vascular dementia.

There are several limitations to consider upon interpreting the results of our study. First, as Alzheimer\'s disease is defined as a chronic neurodegenerative disease that usually starts slowly and worsens over time,[48](#acn3633-bib-0048){ref-type="ref"} therefore the follow‐up duration of 8 years may not have been enough to fully determine the effects of smoking cessation on Alzheimer\'s disease. We also did not take into account other neurodegenerative diseases such as Parkinson\'s disease and amyotrophic lateral sclerosis, which might also be related to smoking. Future studies with a longer follow‐up duration, including other possible related neurologic disorders are needed to validate the findings of our results. Second, as the change in smoking habit was not monitored after the second health examination, possible changes in smoking habit were not accounted for. Third, as the smoking status was determined by a questionnaire, it may not reflect the exact smoking status of each participant. Thus, future studies that use biomarkers as a way of determining smoking status are needed to validate our findings. Also, we could not determine smoking duration among smokers, a factor which may alter the effect of smoking on the risk of dementia. Fourth, we were not able to obtain and adjust for the participant\'s level of education, an important factor upon assessing cognitive function. However, we have adjusted for and conducted subgroup analyses for household income, which could serve as a surrogate marker for education level. Finally, we did not include women in the main analysis, which limits the generalizability of our findings. Therefore, we conducted a separate analysis determining the association between smoking habit change and dementia among women (Table [S3](#acn3633-sup-0001){ref-type="supplementary-material"}). Although there was a tendency toward a decreased risk of dementia according to smoking cessation, we could not obtain significant results since the majority of women were never smokers. Future studies with a large population of women and longer follow‐up duration are needed to elucidate the association between smoking habit change and dementia among women.

Despite these limitations, to the best of knowledge, this is the first study to examine the association between smoking cessation and dementia, using an Asian population. We have also shown that smokers who quit for a prolonged period may benefit from decreased risk of dementia. Furthermore, the relatively large study population and wide range of potential confounding covariates also add to the strengths of this study. Finally, the results were consistent across extensive sensitivity and stratified analyses, reinforcing the reliability of our findings.

In conclusion, smokers should be encouraged to quit in order to reduce the risk of developing dementia. Smoking should be understood as a risk factor for dementia, especially in the elderly population as our study showed, and proper education regarding the benefit of smoking cessation should be done. Future studies with a longer follow‐up duration investigating the effect of smoking cessation on Alzheimer\'s disease are needed.
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**Table S1.** Sensitivity analysis of the effect of smoking habit change on the risk of developing dementia by excluding events that occurred within the first four and six years, respectively.

**Table S2.** Effect of smoking habit change on the risk of developing dementia with never smoker being the reference group.

**Table S3.** Effect of smoking habit change on the risk of developing dementia among women.
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Click here for additional data file.
